Scholar Rock Holding Corp (SRRK)
15.10
+0.14
(+0.97%)
USD |
NASDAQ |
May 02, 16:00
Scholar Rock Price to Book Value: 5.222 for May 2, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 02, 2024 | 5.222 |
| May 01, 2024 | 5.172 |
| April 30, 2024 | 5.072 |
| April 29, 2024 | 5.148 |
| April 26, 2024 | 5.024 |
| April 25, 2024 | 4.826 |
| April 24, 2024 | 4.871 |
| April 23, 2024 | 5.114 |
| April 22, 2024 | 4.840 |
| April 19, 2024 | 4.788 |
| April 18, 2024 | 4.823 |
| April 17, 2024 | 4.737 |
| April 16, 2024 | 4.840 |
| April 15, 2024 | 4.609 |
| April 12, 2024 | 4.650 |
| April 11, 2024 | 4.899 |
| April 10, 2024 | 4.847 |
| April 09, 2024 | 5.124 |
| April 08, 2024 | 5.013 |
| April 05, 2024 | 4.975 |
| April 04, 2024 | 4.979 |
| April 03, 2024 | 5.266 |
| April 02, 2024 | 5.435 |
| April 01, 2024 | 5.805 |
| March 28, 2024 | 6.140 |
| Date | Value |
|---|---|
| March 27, 2024 | 5.342 |
| March 26, 2024 | 5.186 |
| March 25, 2024 | 5.535 |
| March 22, 2024 | 5.667 |
| March 21, 2024 | 5.947 |
| March 20, 2024 | 5.687 |
| March 19, 2024 | 5.238 |
| March 18, 2024 | 4.564 |
| March 15, 2024 | 4.996 |
| March 14, 2024 | 5.11 |
| March 13, 2024 | 5.526 |
| March 12, 2024 | 5.604 |
| March 11, 2024 | 5.492 |
| March 08, 2024 | 5.728 |
| March 07, 2024 | 5.404 |
| March 06, 2024 | 5.526 |
| March 05, 2024 | 5.337 |
| March 04, 2024 | 5.182 |
| March 01, 2024 | 5.290 |
| February 29, 2024 | 5.229 |
| February 28, 2024 | 5.661 |
| February 27, 2024 | 5.762 |
| February 26, 2024 | 5.350 |
| February 23, 2024 | 5.263 |
| February 22, 2024 | 5.273 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8353
Minimum
Jul 01 2022
27.55
Maximum
Dec 23 2020
4.478
Average
3.899
Median
May 20 2021
Price to Book Value Benchmarks
| Regeneron Pharmaceuticals Inc | 3.962 |
| Ocular Therapeutix Inc | 9.565 |
| Alpine Immune Sciences Inc | 12.91 |
| Keros Therapeutics Inc | 6.182 |
| X4 Pharmaceuticals Inc | 3.582 |
Price to Book Value Related Metrics
| PS Ratio | 26.62 |
| PEG Ratio | -2.971 |
| Price | 15.10 |
| Earnings Yield | -13.17% |
| Market Cap | 1.176B |
| PEGY Ratio | -2.971 |